Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

157.70
-3.7700-2.33%
Pre-market: 159.071.37+0.87%05:01 EDT
Volume:3.38M
Turnover:536.85M
Market Cap:244.59B
PE:23.61
High:161.33
Open:160.77
Low:157.54
Close:161.47
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.34
T/O Rate:0.23%
Dividend:3.16
Dividend Rate:2.01%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.86
PE(LYR):24.11

Loading ...

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

TradingKey
·
Sep 28

AstraZeneca Advances Friday, Outperforms Market

Dow Jones
·
Sep 26

AstraZeneca sBLA for Imfinzi combination accepted, granted Priority Review

TIPRANKS
·
Sep 25

AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy

MT Newswires Live
·
Sep 25

AstraZeneca PLC Stock Falls Thursday, Outperforms Market

Dow Jones
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

AstraZeneca (AZN) Receives a Buy from RBC Capital

TIPRANKS
·
Sep 24

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Sep 24

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

TradingKey
·
Sep 23

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday as Traders Await Developments in US-Iran Talks

MT Newswires Live
·
Sep 23

AstraZeneca's Asthma Maintenance Treatment Gets EU Approval

MT Newswires Live
·
Sep 23

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 22

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

AstraZeneca's Alexion Gets Positive EU Recommendation for Klygefa in Rare Muscle Disease

MT Newswires Live
·
Sep 18

AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer

MT Newswires Live
·
Sep 18

AstraZeneca’s BLA for efzimfotase alfa accepted, granted Priority Review by FDA

TIPRANKS
·
Sep 18

AstraZeneca Wins FDA Priority Review for Rare Bone Disease Drug

MT Newswires Live
·
Sep 18

AstraZeneca Advances Thursday, Outperforms Market

Dow Jones
·
Sep 18

AstraZeneca, Daiichi Breast-Cancer Drug Gets Nod in England After U.S. Pharma Deal

Dow Jones
·
Sep 17